HR Execs on the Move

Relmada

www.relmada.com

 
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.relmada.com
  • 880 Third Avenue 12th Floor
    New York, PA USA 10022
  • Phone: 646.876.3459

Executives

Name Title Contact Details

Similar Companies

UT Medical Group

UT Medical Group is the private practice arm of the University of Tennessee Health Science Center (UTHSC) faculty. Because the physicians in our group are actively involved in teaching and research, they remain current with the latest medical developments. As a not-for-profit, non-tax-supported group practice, UT Medical Group is dedicated to quality patient care, medical education, and medical research. This allows us to offer many unique, advanced health care services to people in the Mid-South at competitive prices. Ties to UTHSC allow the physicians at UT Medical Group access to the latest treatments, special protocols and labs, as well as a broad spectrum of professionals with advanced degrees in nursing, nutrition, pharmacology, psychology, and more. This involvement benefits not only our patients' treatments, but keeps the physicians at the top of their fields.  

www.mavericktx.com

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.

Brownsboro Park Retirement Community

Brownsboro Park Retirement Community is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Harbor Chase Of Auburn Hills

Harbor Chase Of Auburn Hills is a Auburn Hills, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

American Medical Home Health Services and Home Resources

American Medical Home Health Services & Home Resources is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.